GARDP Welcomes G7 Support for its Pivotal Work to Counter Antimicrobial Resistance
The Global Antibiotic Research and Development Partnership (GARDP) welcomes the recent declaration by the G7 health ministers, which commits to national and international efforts to tackle rising Antimicrobial Resistance (AMR).
The G7 ministers signaled strong support for GARDP’s pivotal work. They underlined “the importance of closing GARDP’s funding gap to advance GARDP’s 5by5 initiative to deliver five new treatments by 2025”.
The G7 Health Ministers Declaration also welcomed the antibiotics access initiative, SECURE, co-developed by GARDP and the World Health Organization (WHO) in collaboration with other international bodies, to expand access to essential antibiotics. These will include new antibiotics to treat drug-resistant infections, but also existing antibiotics that are not widely available, or face frequent supply chain interruptions and shortages.
AMR NEWS
Every two weeks in your inbox
Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!